These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31335204)

  • 1. The Beneficial Effect of the Mobile Application
    Chatzakis C; Floros D; Papagianni M; Tsiroukidou K; Kosta K; Vamvakis A; Koletsos N; Hatziagorou E; Tsanakas I; Mastorakos G
    Diabetes Technol Ther; 2019 Nov; 21(11):627-634. PubMed ID: 31335204
    [No Abstract]   [Full Text] [Related]  

  • 2. Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.
    Spaans E; van Hateren KJJ; Groenier KH; Bilo HJG; Kleefstra N; Brand PLP
    Eur J Pediatr; 2018 Dec; 177(12):1831-1836. PubMed ID: 30238153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.
    Home PD; Lindholm A; Riis A;
    Diabet Med; 2000 Nov; 17(11):762-70. PubMed ID: 11131100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a glucose meter connected to a mobile app on glycemic control and adherence to self-care tasks in patients with T1DM and LADA: a parallel-group, open-label, clinical treatment trial.
    de Oliveira FM; Calliari LEP; Feder CKR; de Almeida MFO; Pereira MV; de Almeida Fagundes Alves MTT; Garcia SAD; Reis LDD; Salles JEN
    Arch Endocrinol Metab; 2021 Nov; 65(2):185-197. PubMed ID: 33905630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ELKa, the Electronic Device for Prandial Insulin Dose Calculation, on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus: A Randomized Controlled Trial.
    Kowalska A; Piechowiak K; Ramotowska A; Szypowska A
    J Diabetes Res; 2017; 2017():1708148. PubMed ID: 28232949
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status and trends in the use of insulin analogs, insulin delivery systems and their association with glycemic control: comparison of the two consecutive recent cohorts of Japanese children and adolescents with type 1 diabetes mellitus.
    Yamamoto Y; Kikuchi T; Urakami T; Goto M; Tsubouchi K; Sasaki G; Mizuno H; Abe Y; Kitsuda K; Amemiya S; Sugihara S
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):1-9. PubMed ID: 30517078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Welltang - A smart phone-based diabetes management application - Improves blood glucose control in Chinese people with diabetes.
    Zhou W; Chen M; Yuan J; Sun Y
    Diabetes Res Clin Pract; 2016 Jun; 116():105-10. PubMed ID: 27321324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monthly Video-Consultation for Children With Type 1 Diabetes Using a Continuous Glucose Monitoring System: Design of ViDiKi, a Multimethod Intervention Study to Evaluate the Benefit of Telemedicine.
    Frielitz FS; Müller-Godeffroy E; Hübner J; Eisemann N; Dördelmann J; Menrath I; Katalinic A; Hiort O; von Sengbusch S
    J Diabetes Sci Technol; 2020 Jan; 14(1):105-111. PubMed ID: 31315446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.
    Herrmann K; Frias JP; Edelman SV; Lutz K; Shan K; Chen S; Maggs D; Kolterman OG
    Postgrad Med; 2013 May; 125(3):136-44. PubMed ID: 23748514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of mobile application based interactive peer support on glycemic control in patients with type 1 diabetes mellitus].
    Zheng XY; Yang DZ; Liu ZY; Yan JH; Weng JP; Luo SH
    Zhonghua Nei Ke Za Zhi; 2019 Dec; 58(12):889-893. PubMed ID: 31775451
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI.
    Maiorino MI; Bellastella G; Petrizzo M; Improta MR; Brancario C; Castaldo F; Olita L; Giugliano D
    Endocrine; 2014 Jun; 46(2):256-62. PubMed ID: 24078410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial.
    Ramotowska A; Szypowska A
    Diabetes Metab Res Rev; 2014 Feb; 30(2):146-53. PubMed ID: 24115314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
    Pańkowska E; Szypowska A; Lipka M; Szpotańska M; Błazik M; Groele L
    Pediatr Diabetes; 2009 Aug; 10(5):298-303. PubMed ID: 19175902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of a Mobile Phone Application on Quality of Life in Patients With Type 1 Diabetes Mellitus: A Randomized Controlled Trial.
    Drion I; Pameijer LR; van Dijk PR; Groenier KH; Kleefstra N; Bilo HJ
    J Diabetes Sci Technol; 2015 May; 9(5):1086-91. PubMed ID: 25963412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring pilot in low-income type 1 diabetes patients.
    Sequeira PA; Montoya L; Ruelas V; Xing D; Chen V; Beck R; Peters AL
    Diabetes Technol Ther; 2013 Oct; 15(10):855-8. PubMed ID: 23865840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.